Item 8.01 Other Events
On December 16, 2020, Proteostasis Therapeutics, Inc. ("Proteostasis" or the
"Company") adjourned its special meeting of stockholders, held on December 16,
2020 at 9:00 AM Eastern, to December 22, 2020 at 9:00 AM Eastern, in order to
provide stockholders sufficient time to consider new information pertaining to
the Company's entry into a subscription agreement on December 14, 2020 with
certain purchasers for the sale by the Company in a private placement of shares
of the Company's common stock. Accordingly, the record date for the Proteostasis
stockholders entitled to receive a dividend in the form of a contingent value
right, which is immediately prior to the effectiveness of the merger, is now
anticipated to be December 22, 2020. Stockholders did not vote on any of the
proposals prior to adjournment and all proposals will be voted on at the
reconvened meeting.
The Proteostasis special meeting will be reconvened on December 22, 2020 at 9:00
AM Eastern for stockholders to vote on all proposals. The reconvened special
meeting will be held in a virtual-only format via live audio webcast at
www.proxydocs.com/PTI.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
PROTEOSTASIS THERAPEUTICS, INC. 